There have been a further no Coronavirus-related deaths and 582 new cases according to figures released by the health authorities this evening.
5 of today’s cases are in Laois meaning the county’s 14-day rate drops to 76.7 and remains below 80.
Of the cases notified today:
- 290 are men / 291 are women
- 74% are under 45 years of age
- The median age is 32 years old
- 156 in Dublin, 23 in Meath, 19 in Donegal, 15 in Louth, 14 in Kildare and the remaining 198 cases are spread across 20 other counties.
As of 8am today, 345 COVID-19 patients are hospitalised, of which 83 are in ICU. 24 additional hospitalisations in the past 24 hours.
As of March 15, 620,580 doses of COVID-19 vaccine have been administered in Ireland:
- 455,182 people have received their first dose
- 165,398 people have received their second dose
The COVID-19 Dashboard provides up-to-date information on the key indicators of COVID-19 in the community including daily data on Ireland’s COVID-19 Vaccination Programme.
New Cases in Laois
- March 17 – 5
- March 16 – 6
- March 15 – 4
- March 14 – 2
- March 13 – 5
- March 12 – 3
- March 11 – 2
- March 10 – 8
- March 9 – 3
- March 8 – 1
- March 7 – 5
- March 6 – 8
- March 5 – 5
- March 4 – 10
- March 3 – 4
- March 2 – 11
14-day case rate in Laois per 100,000 population
- March 17 – 76.7
- March 16 – 77.9
- March 15 – 86.2
- March 14 – 81.5
- March 13 – 93.3
- March 12 – 103.9
- March 11 – 118.1
- March 10 – 133.4
- March 9 – 135.8
- March 8 – 157
- March 7 – 168.8
- March 6 – 177.1
- March 5 – 183
- March 4 – 211.3
- March 3 – 213.7
- March 2 – 231.4
New cases in Laois during past 14 days
- March 17 – 65
- March 16 – 66
- March 15 – 73
- March 14 – 69
- March 13 – 79
- March 12 – 88
- March 11 – 100
- March 10 – 113
- March 9 – 115
- March 8 – 133
- March 7 – 143
- March 6 – 150
- March 5 – 155
- March 4 – 179
- March 3 – 181
- March 2 – 196
EU Regulator says AstraZeneca is safe
The European Union’s medicines agency has said the Oxford-AstraZeneca coronavirus vaccine is “safe and effective” to use following an investigation into reports of blood clots in a small number of recipients.
The European Medicines Agency said the benefits outweigh the risks – and the vaccine is not linked to an “overall risk” of blood clots.
However, the agency’s safety committee has also said it can’t rule out a potential link with a “small number of cases” of a rare clotting disorder occurring after the vaccination.
